These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients. Pochon C; Voigt S Front Microbiol; 2018; 9():3294. PubMed ID: 30687278 [TBL] [Abstract][Full Text] [Related]
7. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Manuel O; Estabrook M; Clin Transplant; 2019 Sep; 33(9):e13511. PubMed ID: 30817023 [TBL] [Abstract][Full Text] [Related]
8. Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes. Kim YJ; Waghmare A; Xie H; Holmberg L; Pergam SA; Jerome KR; Leisenring WM; Ogimi C; Campbell AP; Englund JA; Boeckh M Blood Adv; 2022 Sep; 6(18):5307-5316. PubMed ID: 35446933 [TBL] [Abstract][Full Text] [Related]
9. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Boeckh M Br J Haematol; 2008 Nov; 143(4):455-67. PubMed ID: 18785968 [TBL] [Abstract][Full Text] [Related]
10. Approach to hematopoietic cell transplant candidates with respiratory viral detection. Kim SR; Waghmare A; Hijano DR Front Pediatr; 2023; 11():1339239. PubMed ID: 38304442 [TBL] [Abstract][Full Text] [Related]
12. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. von Lilienfeld-Toal M; Berger A; Christopeit M; Hentrich M; Heussel CP; Kalkreuth J; Klein M; Kochanek M; Penack O; Hauf E; Rieger C; Silling G; Vehreschild M; Weber T; Wolf HH; Lehners N; Schalk E; Mayer K Eur J Cancer; 2016 Nov; 67():200-212. PubMed ID: 27681877 [TBL] [Abstract][Full Text] [Related]
15. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867 [TBL] [Abstract][Full Text] [Related]
16. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271 [TBL] [Abstract][Full Text] [Related]
18. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Shah DP; Shah PK; Azzi JM; Chemaly RF Cancer Lett; 2016 Jan; 370(2):358-64. PubMed ID: 26582658 [TBL] [Abstract][Full Text] [Related]
19. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients. Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Milano F; Englund JA; Boeckh M J Clin Virol; 2022 Jun; 150-151():105152. PubMed ID: 35447514 [TBL] [Abstract][Full Text] [Related]
20. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Fontana L; Strasfeld L Infect Dis Clin North Am; 2019 Jun; 33(2):523-544. PubMed ID: 30940462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]